Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Maria Gamper

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
BMC Cancer|March 1, 2012
Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapyVerena Meraner, Eva-Maria Gamper, Anna Grahmann, et al.
Pharmacoeconomics - Open|May 2, 2024
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country TariffsMicha J Pilz, Simone Seyringer, Imad Al-Naesan, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2011
Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlatesEva-Maria Gamper, Johannes Maria Giesinger, Anne Oberguggenberger, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical RoutineEva Maria Gamper, Virginie Nerich, Monika Sztankay, et al.
Endocrine-Related Cancer|May 26, 2020
Health-related quality of life in neuroendocrine neoplasia: a critical reviewBenjamin Easton White, Maralyn R Druce, Simona Grozinsky-Glasberg, et al.
Psycho-Oncology|November 13, 2013
The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank developmentEva-Maria Gamper, Mogens Groenvold, Morten Aa Petersen, et al.
Journal of Patient-Reported Outcomes|May 2, 2024
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general populationMicha J Pilz, Fanny L C Loth, Sandra Nolte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 26, 2022
The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United KingdomMicha Johannes Pilz, Sandra Nolte, Gregor Liegl, et al.
Health and Quality of Life Outcomes|May 7, 2016
Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)Eva-Maria Gamper, Morten Aa Petersen, Neil Aaronson, et al.
Breast Cancer Research and Treatment|February 12, 2011
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)Anne Oberguggenberger, Michael Hubalek, Monika Sztankay, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
BMC Cancer|March 1, 2012
Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapyVerena Meraner, Eva-Maria Gamper, Anna Grahmann, et al.
Pharmacoeconomics - Open|May 2, 2024
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country TariffsMicha J Pilz, Simone Seyringer, Imad Al-Naesan, et al.
Acta Oncologica (Stockholm, Sweden)|December 2, 2011
Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlatesEva-Maria Gamper, Johannes Maria Giesinger, Anne Oberguggenberger, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Evaluation of Noncompletion Bias and Long-Term Adherence in a 10-Year Patient-Reported Outcome Monitoring Program in Clinical RoutineEva Maria Gamper, Virginie Nerich, Monika Sztankay, et al.
Endocrine-Related Cancer|May 26, 2020
Health-related quality of life in neuroendocrine neoplasia: a critical reviewBenjamin Easton White, Maralyn R Druce, Simona Grozinsky-Glasberg, et al.
Psycho-Oncology|November 13, 2013
The EORTC emotional functioning computerized adaptive test: phases I-III of a cross-cultural item bank developmentEva-Maria Gamper, Mogens Groenvold, Morten Aa Petersen, et al.
Journal of Patient-Reported Outcomes|May 2, 2024
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general populationMicha J Pilz, Fanny L C Loth, Sandra Nolte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 26, 2022
The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United KingdomMicha Johannes Pilz, Sandra Nolte, Gregor Liegl, et al.
Health and Quality of Life Outcomes|May 7, 2016
Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT)Eva-Maria Gamper, Morten Aa Petersen, Neil Aaronson, et al.
Breast Cancer Research and Treatment|February 12, 2011
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)Anne Oberguggenberger, Michael Hubalek, Monika Sztankay, et al.
Pageof 4